Literature DB >> 11936775

Effect of antisense oligonucleotides to nuclear factor-kappaB on the survival of LPS-induced ARDS in mouse.

Hiroki Saitoh1, Tohru Masuda, Xiao Ye Zhang, Sanae Shimura, Kunio Shirato.   

Abstract

Because nuclear factor (NF)-kappaB-regulated cytokines, including tumor necrosis factor-alpha (TNF-alpha), from monocytes and macrophages have been implicated in the pathogenesis and development of septic shock and acute respiratory distress syndrome (ARDS), the effect of the antisense oligonucleotide to the p65 subunit of NF-kappaB on the survival of lipopolysaccharide (LPS)-induced ARDS in BALB/c mice was examined. None and 70% of the animals died of diffuse hemorrhagic lung edema 1 to 2.5 days after intraperitoneal administration of 10 and 20 mg/kg LPS alone, respectively. Intravenously administered antisense oligonucleotide alone did not produce any significant changes in the behavior or lung histology. After intravenous administration of the anti-sense oligonucleotide, both peripheral blood monocytes and alveolar macrophages in bronchoalveolar lavage fluid were confirmed to contain sufficiently large amounts of intracellular antisense oligonucleotides for their function usingfluorescein isothiocyanate (FTCC)-labeled microscopy. The antisense oligonucleotide administered 6 hours before the intraperitoneal administration of LPS significantly decreased the survival rate with the progress of hemorrhagic edema in lung histology; 90% and 100% of animals treated with the antisense oligonuleotide died 0.5 to 1.5 days after the administration of 10 and 20 mg/kg LPS, respectively. These findings suggest that the suppression of cytokines and mediators in monocytes and alveolar macrophages by the antisense oligonucleotide to the p65 subunit of NF-kappaB worsens the survival of LPS-induced ARDS in mice with the progress of hemorrhagic lung edema.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936775     DOI: 10.1080/019021402753570518

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.

Authors:  Cristina M Alvira; Aida Abate; Guang Yang; Phyllis A Dennery; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

Review 2.  Clinical review: gene-based therapies for ALI/ARDS: where are we now?

Authors:  James Devaney; Maya Contreras; John G Laffey
Journal:  Crit Care       Date:  2011-06-20       Impact factor: 9.097

3.  Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats.

Authors:  Ning Li; Yuanbin Song; Wei Zhao; Tingting Han; Shuhui Lin; Oscar Ramirez; Li Liang
Journal:  BMC Physiol       Date:  2016-12-28

4.  Up-regulation of miR-146b-3p protects septic mice with acute respiratory distress syndrome by inhibiting PI3K/AKT signaling pathway.

Authors:  Yao Liu; Jin-Qiang Zhu; Xiao-Hong Jin; Mei-Ping Dong; Jun-Fen Zheng
Journal:  J Bioenerg Biomembr       Date:  2020-06-02       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.